Haemonetics Corp. (HAE)
61.19
+0.52
(+0.86%)
USD |
NYSE |
Feb 20, 16:00
62.00
+0.81
(+1.32%)
Pre-Market: 06:34
Haemonetics Market Cap : 2.844B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 195.12B |
| Boston Scientific Corp. | 110.60B |
| DexCom, Inc. | 28.13B |
| Masimo Corp. | 9.405B |
| Stryker Corp. | 145.51B |
Market Cap Related Metrics
| PE Ratio | 16.81 |
| PS Ratio | 2.234 |
| PEG Ratio | 0.3889 |
| Price to Book Value | 3.120 |
| Price to Free Cash Flow | 9.558 |
| Price | 61.19 |
| Earnings Yield | 5.95% |
| PEGY Ratio | 0.3889 |
| Operating PE Ratio | 12.10 |
| Normalized PE Ratio | 16.78 |